In summary, we report for the first time, three new and potent ChAT ligands identified using our novel hierarchical virtual screening strategy, with an aim of further optimizing and developing these novel ligands into in vivo PET tracer biomarkers for the early diagnosis and prevention of AD and other related neurogenerative disorders. Here, CHAT is linked to Alzheimer disease.